COST

940.07

-1.39%↓

151.86

+1.35%↑

STZ

156.75

+1.63%↑

GIS

46.22

+4.08%↑

MKC

61.89

+0.93%↑

COST

940.07

-1.39%↓

151.86

+1.35%↑

STZ

156.75

+1.63%↑

GIS

46.22

+4.08%↑

MKC

61.89

+0.93%↑

COST

940.07

-1.39%↓

151.86

+1.35%↑

STZ

156.75

+1.63%↑

GIS

46.22

+4.08%↑

MKC

61.89

+0.93%↑

COST

940.07

-1.39%↓

151.86

+1.35%↑

STZ

156.75

+1.63%↑

GIS

46.22

+4.08%↑

MKC

61.89

+0.93%↑

COST

940.07

-1.39%↓

151.86

+1.35%↑

STZ

156.75

+1.63%↑

GIS

46.22

+4.08%↑

MKC

61.89

+0.93%↑

Home・Aktien・Lifecore Biomedical Inc

Lifecore Biomedical Inc

Geschlossen

BrancheKonsumgüter defensiv

8.67 2.12

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

8.61

Max

8.7

Schlüsselkennzahlen
By Trading Economics
Einkommen	-7.9M -10M
Verkäufe	-5.3M 31M
Gewinnspanne	-32.116
Angestellte	406

Dividenden
By Dow Jones
Nächstes Ergebnis	6. Feb. 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	33M 274M
Vorheriger Eröffnungskurs	6.55
Vorheriger Schlusskurs	8.67

Lifecore Biomedical Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

1. Feb. 2026, 23:59 UTC

Market Talk

Oil Prices Fall Amid Signs of U.S.-Iran Negotiations -- Market Talk

1. Feb. 2026, 23:47 UTC

Market Talk

Nikkei May Rise as Weaker Yen Supports Earnings Hopes -- Market Talk

1. Feb. 2026, 23:44 UTC

Market Talk

Gold Falls as Markets Further Price in Warsh-Led Fed -- Market Talk

1. Feb. 2026, 12:47 UTC

Akquisitionen, Fusionen, Übernahmen

KKR-Led Group Set to Buy Singapore Data-Center Firm Valued at Over $10 Billion -- Update

1. Feb. 2026, 03:02 UTC

Akquisitionen, Fusionen, Übernahmen

KKR-Led Group Set to Buy Singapore Data-Center Firm Valued at Over $10 Billion

1. Feb. 2026, 03:01 UTC

Akquisitionen, Fusionen, Übernahmen

KKR Consortium Currently Owns Near 20% Stake in STT GDC

1. Feb. 2026, 03:01 UTC

Akquisitionen, Fusionen, Übernahmen

KKR Consortium Acquiring Remaining Stake in STT GDC With Singtel, Sources Say

31. Jan. 2026, 18:48 UTC

Akquisitionen, Fusionen, Übernahmen

Negotiations Over $100B OpenAI, Nvidia Deal Stall -- Update

31. Jan. 2026, 16:40 UTC

Ergebnisse

'All Boats Are Rising' in Data and Memory, Says Western Digital's CFO. Just Look at the Stocks. -- Barrons.com

31. Jan. 2026, 09:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

30. Jan. 2026, 23:47 UTC

Akquisitionen, Fusionen, Übernahmen

Negotiations Over $100B OpenAI, Nvidia Deal Stall -- WSJ

30. Jan. 2026, 23:47 UTC

Akquisitionen, Fusionen, Übernahmen

Nvidia, OpenAI in Talks to Revise Nature of Broader Partnership, Sources Say -- WSJ

30. Jan. 2026, 23:47 UTC

Akquisitionen, Fusionen, Übernahmen

Nvidia CEO Jensen Huang Has Privately Told Colleagues That Deal Is Non-Binding, Sources Say -- WSJ

30. Jan. 2026, 23:47 UTC

Akquisitionen, Fusionen, Übernahmen

Nvidia's Huang Has Privately Criticized OpenAI's Business Strategy, Sources Say -- WSJ

30. Jan. 2026, 23:47 UTC

Akquisitionen, Fusionen, Übernahmen

OpenAI, Nvidia Deal Talks Stalled in Recent Months, Sources Say -- WSJ

30. Jan. 2026, 23:47 UTC

Akquisitionen, Fusionen, Übernahmen

Nvidia's Huang Expressed Concerns Over Competition OpenAI Faces From Anthropic, Google, Sources Say -- WSJ

30. Jan. 2026, 23:47 UTC

Akquisitionen, Fusionen, Übernahmen

Nvidia Weighing Equity Investment of Tens of Billions of Dollars Into OpenAI, Sources Say -- WSJ

30. Jan. 2026, 23:47 UTC

Akquisitionen, Fusionen, Übernahmen

Negotiations Over $100B OpenAI, Nvidia Deal Stall, Sources Say -- WSJ

30. Jan. 2026, 23:41 UTC

Market Talk

Deckers Outdoor Seen as Undervalued -- Market Talk

30. Jan. 2026, 23:12 UTC

Akquisitionen, Fusionen, Übernahmen

Supreme Court of British Columbia Approves Fortescue Purchase of Alta Copper

30. Jan. 2026, 22:20 UTC

Ergebnisse

Verizon Posts Strong Subscriber Gains Under New CEO -- WSJ

30. Jan. 2026, 22:10 UTC

Market Talk

Disney CEO's Exit Plan Marks Abrupt End to Messy Succession -- Market Talk

30. Jan. 2026, 21:50 UTC

Market Talk

Ergebnisse

Tech, Media & Telecom Roundup: Market Talk

30. Jan. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

30. Jan. 2026, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

30. Jan. 2026, 21:42 UTC

Ergebnisse

These Stocks Are Today's Movers: Apple, Verizon, SoFi, Sandisk, Western Digital, Unity Software, Exxon, and More -- Barrons.com

30. Jan. 2026, 21:36 UTC

Ergebnisse

GE Aerospace and GE Vernova Issue Their Annual Reports. They Contain Messages for Investors. -- Barrons.com

30. Jan. 2026, 21:33 UTC

Ergebnisse

Tesla Stock Rebounds From Earnings Dip. SpaceX Is Helping. -- Barrons.com

30. Jan. 2026, 20:42 UTC

Ergebnisse

These Stocks Are Today's Movers: Apple, Verizon, SoFi, Sandisk, Western Digital, Unity Software, Exxon, and More -- Barrons.com

30. Jan. 2026, 20:37 UTC

Akquisitionen, Fusionen, Übernahmen

Why a Ruling Over CK Hutchison's Panama Canal Ports Matters -- and What's Next -- WSJ

Peer-Vergleich

Kursveränderung

Lifecore Biomedical Inc Prognose

Rating-Konsens

By TipRanks

Buy

4 ratings

Buy

Halten

Sell

Basierend auf 4 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Lifecore Biomedical Inc – Dist abgegeben haben.

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Lifecore Biomedical Inc

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacturing of injectable grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.